Dan Brennan
Stock Analyst at TD Cowen
(4.11)
# 484
Out of 5,135 analysts
130
Total ratings
50.51%
Success rate
14.37%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintains: Hold | $53 → $43 | $39.76 | +8.15% | 4 | Feb 13, 2026 | |
| TXG 10x Genomics | Maintains: Hold | $18 → $19 | $19.57 | -2.91% | 6 | Feb 13, 2026 | |
| RVTY Revvity | Maintains: Buy | $120 → $124 | $97.74 | +26.87% | 4 | Feb 3, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $696 → $683 | $513.56 | +32.99% | 15 | Jan 30, 2026 | |
| ILMN Illumina | Maintains: Hold | $115 → $140 | $120.09 | +16.58% | 14 | Jan 7, 2026 | |
| DHR Danaher | Maintains: Buy | $260 → $270 | $208.56 | +29.46% | 7 | Jan 7, 2026 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $9.27 | +29.45% | 4 | Jan 7, 2026 | |
| MDXH MDxHealth | Maintains: Buy | $5 → $7 | $3.68 | +90.22% | 2 | Nov 13, 2025 | |
| WAT Waters | Maintains: Hold | $345 → $390 | $327.53 | +19.07% | 4 | Nov 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $74 → $90 | $103.36 | -12.93% | 7 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $8 → $9 | $4.37 | +105.95% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $162 | $126.94 | +27.62% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $72 | $107.42 | -32.97% | 3 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $10.26 | +16.96% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $15.87 | -5.48% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $21.05 | +52.02% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $92.04 | +19.51% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $2.98 | -15.97% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $56.16 | +31.77% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $215.53 | -18.80% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $158.00 | +58.23% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $48.05 | +6.14% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $12.57 | +345.51% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $182.13 | +199.79% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.63 | +820.25% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $96.50 | +140.41% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,375.57 | -36.03% | 3 | Oct 7, 2020 |
Bruker
Feb 13, 2026
Maintains: Hold
Price Target: $53 → $43
Current: $39.76
Upside: +8.15%
10x Genomics
Feb 13, 2026
Maintains: Hold
Price Target: $18 → $19
Current: $19.57
Upside: -2.91%
Revvity
Feb 3, 2026
Maintains: Buy
Price Target: $120 → $124
Current: $97.74
Upside: +26.87%
Thermo Fisher Scientific
Jan 30, 2026
Maintains: Buy
Price Target: $696 → $683
Current: $513.56
Upside: +32.99%
Illumina
Jan 7, 2026
Maintains: Hold
Price Target: $115 → $140
Current: $120.09
Upside: +16.58%
Danaher
Jan 7, 2026
Maintains: Buy
Price Target: $260 → $270
Current: $208.56
Upside: +29.46%
Avantor
Jan 7, 2026
Maintains: Hold
Price Target: $14 → $12
Current: $9.27
Upside: +29.45%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $3.68
Upside: +90.22%
Waters
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $327.53
Upside: +19.07%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $74 → $90
Current: $103.36
Upside: -12.93%
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $4.37
Upside: +105.95%
Oct 14, 2025
Maintains: Buy
Price Target: $150 → $162
Current: $126.94
Upside: +27.62%
Sep 25, 2025
Maintains: Buy
Price Target: $63 → $72
Current: $107.42
Upside: -32.97%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $10.26
Upside: +16.96%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $15.87
Upside: -5.48%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $21.05
Upside: +52.02%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $92.04
Upside: +19.51%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $2.98
Upside: -15.97%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $56.16
Upside: +31.77%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $215.53
Upside: -18.80%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $158.00
Upside: +58.23%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $48.05
Upside: +6.14%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $12.57
Upside: +345.51%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $182.13
Upside: +199.79%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.63
Upside: +820.25%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $96.50
Upside: +140.41%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,375.57
Upside: -36.03%